Acurx Pharmaceuticals, Inc.

US$1.06As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACXPHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (59.10%)
Div yield —
ROE (128.11%)
Biotechnology
Beta (5Y) (2.09)
PE TTM —
TSR TTM (78.88%)
Mkt cap US$5.586M
ROIC (81.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.23
16.17%
(24.59%)
Hold 8|6|9|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(2.81%)
3.75%
13.03%
24.42%
Revenue$M
0.310
0.305
0.320
0.337
10.18%
8.14%
10.16%
14.24%
Peers (US$5.586M)
Cap (US$)
PE
5.771M
—
5.040M
—
Capital
TTM
5Y
10Y
Leveragex
0.637
0.283
0.284
EBIT/Intx
1.014
0.657
0.509
Own earn%
(33.47)
(227.11)
(160.23)
Sh yield%
19.39
27.46
33.52
Owners
Insiders/Inst%
10.48
55.52
Short interest%
3.48
SBC / revenue%
0.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
5